Amsterdam, May 8, 2013 Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today the publication of a clinical guide by the European Menopause and Andropause Society (EMAS) in the journal Maturitas on endometrial assessment in peri and postmenopausal women with summary recommendations.
The main onus of endometrial assessment is to exclude carcinoma of the endometrium and premalignant endometrial hyperplasia. Assessment of the endometrium in the absence of bleeding should be limited to women at high risk of endometrial cancer. Transvaginal ultrasound scanning (TVS) is used for initial assessment to be followed by endometrial biopsy to be undertaken as an outpatient procedure if possible. Hysteroscopy allows direct visualization of the endometrial cavity and any focal lesions. Should results be inconclusive and abnormal or postmenopausal bleeding persist, transvaginal ultrasound should be repeated and hysteroscopy performed.
These and other recommendations presented in EMAS' clinical guide are published in the article: 'EMAS clinical guide: Assessment of the endometrium in peri and postmenopausal women', by Eva Dreisler, Lars Grnlund Poulsen, Sofie Leisby Antonsen, Iuliana Ceausu, Herman Depypere, C. Tamer Erel, Irene Lambrinoudaki, Faustino R. Prez-Lpez, Tommaso Simoncini, Florence Tremollieres, Margaret Rees and Lian Ulrich (10.1016/j.maturitas.2013.03.011).The article appears in Maturitas Volume 75, Issue 2 (June 2013), published by Elsevier.
|Contact: Greyling Peoples|